Discussion of the emergence and therapeutic potential for neuroendocrine prostate cancer

May 18, 2022

The Stoyanova Lab discusses the molecular mechanisms that underly development of neuroendocrine phenotypes in prostate cancer. Congrats to Laura and the team!

https://pubmed.ncbi.nlm.nih.gov/35597438/

May 18, 2022

News Stanford

PreviousDiscovery of SU086 as an inhibitor of glycolysis and a potential treatment strategy for advanced prostate cancer
NextDiscovery of a new metastasis model to assess the role of notch signaling in prostate cancer

Exciting News: Dr. Stoyanova is promoted to a Full Professor at the University of California, Los Angeles

News, UCLA

Congratulations on the Great Achievement, Reva! Reva Patel Receives Dean’s Prize for Excellence in Science at the Undergraduate Research and Creativity Showcase

News

Discussion of the emergence and therapeutic potential for neuroendocrine prostate cancer

PreviousDiscovery of SU086 as an inhibitor of glycolysis and a potential treatment strategy for advanced prostate cancer

NextDiscovery of a new metastasis model to assess the role of notch signaling in prostate cancer

Related Posts ...

Exciting News: Dr. Stoyanova is promoted to a Full Professor at the University of California, Los Angeles

Congratulations on the Great Achievement, Reva! Reva Patel Receives Dean’s Prize for Excellence in Science at the Undergraduate Research and Creativity Showcase